We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
17:00 - 18:00
A3
Gynaecological cancers 1
Alexandra Timea Kirsch-Mangu, Romania;
Remi Nout, The Netherlands
Proffered Papers
Clinical
17:00 - 18:00
Nimotuzumab plus CCRT versus CCRT for locally advanced cervical squamous cell carcinoma: the randomized, phase 3 CC3 study (NCT04678791)
Junjie Wang, China
-1492
17:00 - 18:00
Updates on prospective phase III trial of standard of care therapy with/without SABR for recurrent ovarian cancer (SABR-ROC, KGOG 3064/KROG 2204)
Won Hee Lee, Korea Republic of
-3556
17:00 - 18:00
Post-progression trajectory and survival in oligorecurrent, oligometastatic cervix cancer: Results from international multicentre RetroCOSMOS study.
Supriya Chopra, India
-1754
17:00 - 18:00
hypofractionated versus standard definitive chemoradiotherapy in advanced cervical cancer: interim results of a randomized clinical trial; NCT04831437
Kasra Kolahdouzan, Iran Islamic Republic of
-980
17:00 - 18:00
Hypofractionated Chemoradiotherapy for Locally Advanced Cervical Cancer: Results from the Phase II Randomized HEROICC Trial
Lucas Mendez, Canada
-2296
17:00 - 18:00
The Endoscopy Results of rhSOD in Concurrent Chemoradiotherapy for Cervical Cancer to Prevent Rectal Injury: A Prospective Multi-Center Trial
Jiawei Zhu, China
-653